Alibaba probe unearthed evidence it knowingly let dangerous drugs be sold to U.S. consumers

For eight years, Chinese online retailer Alibaba and its U.S. payment processing company failed to prevent dangerous drugs, chemicals and pill presses from being sold to American customers — even after employees warned of compliance problems, public records show.